Copper-GHK Analogues Show Enhanced Biological Activity for Regeneration

Glycyl-histidyl-lysine (GHK), particularly its copper complex GHK-Cu, is a naturally occurring peptide renowned for its roles in wound healing, skin regeneration, and anti-inflammatory processes. Its therapeutic efficacy is intrinsically linked to its ability to chelate copper ions, forming a stable complex crucial for its biological functions. However, the precise impact of structural modifications on GHK's copper-binding characteristics and subsequent biological activity has remained an area requiring deeper investigation to optimize its therapeutic potential.

The study revealed significant differences in copper-binding properties and biological efficacy among the peptides. Analogue A demonstrated a notably stronger copper-binding affinity, showing a 28% increase in stability constant compared to native GHK-Cu, while Analogue B exhibited a 12% weaker affinity. In cell proliferation assays, GHK-Cu itself stimulated fibroblast growth by 32% at 1 µM after 48 hours compared to untreated controls. Crucially, Analogue A-Cu significantly outperformed both GHK-Cu and Analogue B-Cu, boosting fibroblast proliferation by an impressive 55% (p<0.001) and increasing superoxide dismutase (SOD) enzyme activity by 2.7-fold (p<0.005) at the same concentration, indicating superior antioxidant and regenerative potential. These findings suggest that specific structural modifications can indeed enhance the therapeutic profile of GHK-based peptides.